Sharon M Weber, MD, FACS


  • Chief, Division of Surgical Oncology
  • Medical Director of Surgical Oncology, UW Carbone Cancer Center
  • Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology
Clinic: (608) 263-7502

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375 Clinical Science Center
Madison, Wisconsin 53792-3284


  • MD, University of Wisconsin Medical School, Madison, WI, 1993
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.

Recent Publications

  • Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
    Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM
    World J Surg 2021 Mar 25;
    [PubMed ID: 33768309]

  • Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes.
    Acher AW, Weber SM, Pawlik TM
    Expert Rev Gastroenterol Hepatol 2021 Feb 26; 1-12
    [PubMed ID: 33577361]

  • Clinical and Cost Profile of Controlled Grade B Postoperative Pancreatic Fistula: Rationale for Their Consideration as Low Risk.
    Acher AW, Stahl C, Barrett JR, Schwartz PB, Aiken T, Ronnekleiv-Kelly S, Minter RM, Leverson G, Weber SM, Abbott DE
    J Gastrointest Surg 2021 Feb 08;
    [PubMed ID: 33555526]

  • Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma.
    Xiang JX, Zhang XF, Weber SM, Poultsides G, Fields RC, Hatzaras I, Weiss M, Scoggins C, Idrees K, Shen P, Maithel SK, Pawlik TM
    J Surg Oncol 2021 Mar; 123(4): 978-985
    [PubMed ID: 33497466]

  • Pancreatic cyst characterization: maximum axial diameter does not measure up.
    Awe AM, Rendell VR, Lubner MG, Weber S, Winslow ER
    HPB (Oxford) 2020 Dec 11;
    [PubMed ID: 33317934]

All Publications on PubMed